Clinical trial
Retrospective, Observational Evaluation of the Utilization, Outcomes, and Adverse Events Associated With Orbactiv® for the Treatment of Infections Presumed or Confirmed to be Caused by Gram Positive Bacteria in a Real World Setting
NCT03159403 is registered in ClinicalTrials.gov with Melinta Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective, Observational Evaluation of the Utilization, Outcomes, and Adverse Events Associated With Orbactiv® for the Treatment of Infections Presumed or Confirmed to be Caused by Gram Positive Bacteria in a Real World Setting
- Lead sponsor
- Melinta Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 12, 2017
- Completion date
- March 8, 2018
- Enrollment
- 325 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.